Bin Li - Profile and Investment Details

Investor Profile

Bin Li is a Venture Capital, Private Equity Firm based in Shanghai, China with a diverse investment portfolio that includes companies such as SeekGene, Microtech Medical, Bioheart, Percutek Therapeutics, Singlera Genomics, Hui-Gene Therapeutics, Smartee Denti-Technology, Microread, Creative Biosciences, CMAB BioPharm, Xinzhi Medical, 12 Sigma Technologies, Biomarker Technologies, Quiknos, Jenscare Biotech, SuperbioMed Lighter, Pulse Medical, Urotronic, Sino Vision, Righton, accunome, . Over time, Bin Li has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bin Li is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Enterprise Software, Fundraising, Life Science, Analytics, Manufacturing, Biotechnology, Genomics, Clinical Trials, Research, Marketing, Medical, Information Technology, Therapeutics may find it worthwhile to explore potential connections with Bin Li, as their portfolio suggests a familiarity and interest in this area.

Understanding Bin Li’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.